MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,449 | +74.6% | 2,306 | +44.8% | 0.00% | +50.0% |
| Q2 2023 | $57,519 | +9.5% | 1,592 | +12.7% | 0.00% | 0.0% |
| Q1 2023 | $52,535 | -30.6% | 1,413 | -15.4% | 0.00% | -33.3% |
| Q4 2022 | $75,668 | -4.2% | 1,670 | +48.6% | 0.00% | -25.0% |
| Q3 2022 | $79,000 | +21.5% | 1,124 | +15.5% | 0.00% | +33.3% |
| Q2 2022 | $65,000 | +109.7% | 973 | +162.3% | 0.00% | +200.0% |
| Q1 2022 | $31,000 | +138.5% | 371 | +307.7% | 0.00% | – |
| Q4 2021 | $13,000 | +160.0% | 91 | +250.0% | 0.00% | – |
| Q3 2021 | $5,000 | +400.0% | 26 | +420.0% | 0.00% | – |
| Q2 2021 | $1,000 | -75.0% | 5 | -78.3% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 23 | +21.1% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 19 | +216.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |